Medtronic Drug Eluting Stent

Biocompatibles has an agreement with Abbott Laboratories under which we supply the biocompatible polymer, phosphorylcholine, for use on Medtronic's Endeavor™ Drug Eluting Stent.

Biocompatibles will receive from Abbott the following payments: an up-front payment; a milestone payment triggered by Medtronic's first US sale of the Endeavor stent; and a 1.5% royalty on Medtronic's worldwide sales of the Endeavor stent.